8-K: CareCloud Announces Record-Breaking 2024 Net Income, Resumes Dividends, and Strengthens Balance Sheet

CareCloud reports a transformational turnaround in 2024, achieving GAAP profitability, record cash flow, and resuming dividends, driven by strategic execution and AI-driven innovation.

Summary

• CareCloud, Inc. announced strong financial results for the full year ended December 31, 2024.
• The company achieved a GAAP net income of $7.9 million, a significant improvement from a net loss of $48.7 million in 2023.
• Adjusted EBITDA increased by 56% to $24.1 million, compared to $15.4 million in the previous year.
• Free cash flow saw a substantial increase of 244%, reaching $13.2 million compared to $3.8 million in 2023.
• Revenue for the year was $110.8 million, slightly lower than the $117.1 million reported in 2023.
• For the fourth quarter of 2024, CareCloud reported a GAAP net income of $3.3 million, compared to a net loss of $43.7 million in Q4 2023.
• Adjusted EBITDA for Q4 2024 increased by 73% to $7.1 million, compared to $4.1 million in the same period last year.
• The company fully repaid its credit line with Silicon Valley Bank using internally generated cash flow.
• CareCloud converted 3.5 million shares of Series A Preferred Stock into 26 million common shares, reducing the annual dividend burden by $7.7 million.
• The company is providing 2025 guidance, expecting revenue between $111 and $114 million and adjusted EBITDA between $26 and $28 million.
• Net Income Per Share (EPS) is expected to be $0.10 $0.13 for full year 2025.

Sentiment

Score: 8

Explanation: The document presents a highly positive outlook, highlighting significant improvements in profitability, cash flow, and debt management. The company's strategic focus on AI and cost reduction efforts further contributes to the positive sentiment.

Positives

• CareCloud achieved GAAP profitability with a net income of $7.9 million for 2024.
• Adjusted EBITDA increased significantly by 56% to $24.1 million.
• Free cash flow saw a substantial increase of 244% to $13.2 million.
• The company successfully repaid its Silicon Valley Bank credit line.
• The conversion of Series A Preferred Stock reduces the annual dividend burden by $7.7 million.
• The company is projecting revenue growth and improved profitability for 2025.

Negatives

• Revenue for 2024 was $110.8 million, slightly lower than the $117.1 million reported in 2023.

Risks

• The company's forward-looking statements are subject to risks and uncertainties, including the ability to manage growth, retain customers, and adapt to industry regulations.
• The company faces competition from other companies offering similar products and services.
• Maintaining cost-effective global operations and securing information systems are ongoing challenges.

Future Outlook

CareCloud anticipates full year 2025 revenue of approximately $111 to $114 million and adjusted EBITDA of $26 to $28 million. EPS is expected to be $0.10 to $0.13 for full year 2025.

Management Comments

• AI is supercharging our operations, said A. Hadi Chaudhry, Co-CEO of CareCloud.
• From clinical workflows to revenue cycle automation, AI is making us faster, smarter, and more efficient.
• This will fuel even greater profitability in 2025.
• We've successfully transformed our cost structure and positioned CareCloud for future growth, added Co-CEO Stephen Snyder.
• Norman Roth commented this is our third consecutive quarter of positive GAAP net income and our largest quarterly net income since Q4 2021.
• It was also the highest quarterly adjusted EBITDA we have reported in two years.
• We were able to use the profits and cash flows we generated to fully pay the outstanding balance on our Silicon Valley Bank line of credit.
• We have accomplished what we set out to achieve in 2024, leaving ourselves in a strong position for 2025.

Industry Context

CareCloud's focus on healthcare technology and generative AI solutions aligns with the industry's increasing adoption of AI to improve clinical workflows and revenue cycle management. The company's turnaround and profitability could position it as a strong player in the competitive healthcare technology market.

Comparison to Industry Standards

• It's difficult to provide a precise comparison without specific industry benchmarks for companies of similar size and focus.
• However, the 56% increase in Adjusted EBITDA and 244% increase in free cash flow suggest a strong performance compared to industry averages.
• Companies like Veeva Systems and Cerner (now Oracle Health) are larger players in the healthcare technology space, but CareCloud's focus on AI and specific market segments could differentiate it.
• Comparing CareCloud's growth and profitability metrics against smaller, similarly focused companies would provide a more accurate assessment.

Stakeholder Impact

• Shareholders will benefit from the resumption of dividends and improved financial performance.
• Employees may see increased opportunities due to the company's growth and profitability.
• Customers may benefit from improved technology and services driven by AI innovation.

Next Steps

• CareCloud management will host a conference call to discuss the full year 2024 results.
• The company will continue to focus on AI-driven innovation and strategic execution to drive future growth and profitability.

Key Dates